-
公开(公告)号:WO2022007478A1
公开(公告)日:2022-01-13
申请号:PCT/CN2021/090074
申请日:2021-04-27
申请人: 康希诺生物股份公司
IPC分类号: C07K14/22 , C07K1/10 , A61K39/095 , A61K2039/70 , A61K47/542 , A61K47/544 , A61P31/04 , C07C2601/02 , C07C323/59
摘要: 一种定点突变、定点修饰的蛋白抗原及定点突变和定点修饰蛋白抗原的方法,所述方法包括使用基因密码子扩展技术将非天然氨基酸定点引入到蛋白抗原特定位点,借助非天然氨基酸与修饰剂,所述修饰剂如三棕榈酰-S-甘油半胱氨酸、单磷酰脂质A等受体激动剂,与蛋白抗原定点修饰。定点突变、定点修饰的蛋白抗原的应用,如作为疫苗等用途。
-
公开(公告)号:WO2021227512A1
公开(公告)日:2021-11-18
申请号:PCT/CN2020/139779
申请日:2020-12-27
申请人: 深圳市老年医学研究所 , 吴正治
摘要: 提供一种新型的天然活性多肽Tubulysin U的制备方法,该制备方法的合成路线符合绿色化学标准,尽量利用可再生和可回收性资源,所用试剂毒性较小、反应经处理后对环境污染很小。尤其,该制备方法的总产率较高、立体选择性好、实验操作方便、反应条件温和、分离纯化简单、可用于大量制备。
-
公开(公告)号:WO2021167317A1
公开(公告)日:2021-08-26
申请号:PCT/KR2021/001959
申请日:2021-02-16
申请人: 주식회사 아이바이오코리아
摘要: 본 발명은, 트리틸기가 도입된 수지에 반응용매를 이용하여 아민말단 및 측쇄가 모두 보호된 아미노산 유도체들을 순차적으로 결합시키는 제1 단계; 및 상기 제1 단계의 수지에서 펩타이드를 분리하고 측쇄 보호기들을 제거하는 제2 단계의 공정을 수행함을 특징으로 하는 하기 구조식 (a)의 서열로 표시되는 펩타이드 제조 방법을 제공한다. 구조식 (a) Hyp-Gly-Gln-Asp-Gly-Leu-Ala-Gly-Pro-Lys
-
公开(公告)号:WO2021004973A1
公开(公告)日:2021-01-14
申请号:PCT/EP2020/068902
申请日:2020-07-03
申请人: PURE BIOORGANICS SIA
IPC分类号: C07K1/06 , C07D209/90 , C07C227/20 , C07C271/22 , C07K1/10 , C07K1/113 , C07K7/06 , C07K7/50 , C07B2200/07 , C07C231/12 , C07C2603/18 , C07C269/04 , C07D513/04 , C07D513/22 , C07K7/56
摘要: The present invention relates to the chemical synthesis of α-amanitin and its derivatives. The present invention also relates to intermediate products of the α-amanitin synthesis.
-
公开(公告)号:WO2020124252A1
公开(公告)日:2020-06-25
申请号:PCT/CA2019/051870
申请日:2019-12-19
申请人: RAPID NOVOR INC.
发明人: LE BIHAN, Thierry , MA, Bin , MCDONALD, Zac , LIU, Qixin , TAYLOR, Paul
IPC分类号: G01N33/483 , C12Q1/37 , G01N1/28 , C07K1/107 , C07K1/10
摘要: A method for increasing peptide fragmentation by labelling the peptide at the C-terminal end with a guanidinium group or other basic functional group and distinguishing isobaric amino acids and amino acid combinations of asparagine and glycine-glycine; glutamine and glycine-alanine; and/or glutamine and alanine-glycine, during polypeptide sequencing. The method involves: obtaining a peptide of interest and/or digesting a polypeptide of interest with a protease, such as pepsin, chymotrypsin or trypsin, or by chemical cleavage to produce shorter peptides; reacting the obtained and/or generated peptides with a coupling reagent to derivatize the free C-terminal carboxylic acid function of the peptides, thus adding a basic functional group rendering C-terminal peptide fragment ions detectable by mass spectrometry; selecting a charge state of 2+ or more, and fragmenting the derivatized peptides in a mass spectrometer under conditions effective to generate at least w ions; and detecting the w ions by mass spectrometry, and identifying derivatized peptides which incorporate the additional mass of the basic functional group.
-
公开(公告)号:WO2020124017A3
公开(公告)日:2020-06-18
申请号:PCT/US2019/066351
申请日:2019-12-13
发明人: SRIVASTAVA, Tumul
摘要: The present invention is directed to PNA oligomers that comprise an N-terminal bis- protected-diamine amino acid (e.g., a bis-Fmoc-protected lysine) moiety. The presence of the bis-protected diamine moiety can be used as a purification handle that permits separation between fully elongated PNA oligomer from truncated/capped failure sequences. After purification/separation, the protecting groups can then be removed from the PNA oligomer, and the resulting deprotected PNA oligomer optionally again purified. The methods disclosed herein are particularly useful for purifying longer PNA oligomers (e.g., oligomers of greater than 18 residues in length), including tail-clamp PNA oligomers, and/or PNA oligomers comprising two or more unnatural nucleobases.
-
公开(公告)号:WO2020057089A1
公开(公告)日:2020-03-26
申请号:PCT/CN2019/080350
申请日:2019-03-29
申请人: 深圳翰宇药业股份有限公司
摘要: 本发明属于多肽合成技术领域,本发明公开了一种戈舍瑞林的合成方法,该合成方法包括:将Azagly与树脂进行偶联,得到Azagly-树脂;在Azagly-树脂氨基端依次偶联氨基酸;采用裂解液对得到的肽树脂进行裂解;将裂解后得到的多肽中Arg(NO 2 )的硝基还原为氨基,得到戈舍瑞林;还原采用的体系为氢转移体系SnCl 2 和酸的混合物。
-
公开(公告)号:WO2019108797A1
公开(公告)日:2019-06-06
申请号:PCT/US2018/063070
申请日:2018-11-29
发明人: BLANCHARD, Sophie , COATS, James
摘要: This disclosure generally relates to novel processes for the preparation of drug linker compounds and compositions comprising such drug linker compounds. The presently disclosed methods for synthesizing Fmoc-Val-Cit-PABOH and related compounds have also been found to minimize formation of diastereomeric impurities.
-
公开(公告)号:WO2017018835A1
公开(公告)日:2017-02-02
申请号:PCT/KR2016/008306
申请日:2016-07-28
CPC分类号: C07K7/08
摘要: Disclosed is a method of preparing TDM-621. According to the present invention, conventional problems of a solid-phase synthesis method can be addressed, and thus, high-purity and high-yield TDM-621 can be prepared in a relatively simple method. Therefore, a novel method of preparing TDM-621 according to the present invention is suitable and advantageous in commercially, massively producing TDM-621.
摘要翻译: 公开了一种制备TDM-621的方法。 根据本发明,可以解决固相合成方法的常规问题,因此可以以相对简单的方法制备高纯度和高产率的TDM-621。 因此,根据本发明的制备TDM-621的新方法在商业上大规模生产TDM-621中是合适的和有利的。
-
公开(公告)号:WO2012085279A2
公开(公告)日:2012-06-28
申请号:PCT/EP2011/073974
申请日:2011-12-23
申请人: UNIVERSITEIT GENT , MADDER, Annemieke , HOOGEWIJS, Kurt , DECEUNINCK, Annelies , CARRETTE, Lieselot
CPC分类号: C07K1/113 , C07K1/006 , C07K1/1075 , C07K1/1077 , C07K1/13 , C12N9/0051 , C12Y108/01009
摘要: The present invention relates to a method for cross-linking peptides using an activated furan-moiety. In particular, the present invention provides a method for cross-linking peptides comprising the steps of: a) providing a composition comprising furan-peptides, said furan-peptides comprising at least one amino acid comprising a furan-moiety; b) contacting said composition comprising furan-peptides with second peptides, thereby obtaining a mixture comprising furan-peptides and second peptides; c) adding an activation signal to said mixture of step b), thereby activating said furan-peptides to activated furan-peptides, and d) reacting said activated furan-peptides with said second peptides, thereby cross-linking said activated furan-peptides with said second peptides.
摘要翻译: 本发明涉及使用活化的呋喃部分交联肽的方法。 具体而言,本发明提供了用于交联肽的方法,其包括以下步骤:a)提供包含呋喃肽的组合物,所述呋喃肽包含至少一个包含呋喃部分的氨基酸; b)使所述包含呋喃肽的组合物与第二肽接触,由此获得包含呋喃肽和第二肽的混合物; c)向步骤b)的所述混合物添加活化信号,从而将所述呋喃肽激活成活化的呋喃肽,和d)使所述活化的呋喃肽与所述第二肽反应,由此使所述活化的呋喃肽与 所述第二肽。 p>
-
-
-
-
-
-
-
-
-